- Beta-hydroxy-beta-methylbutyrate monohydrate
- Beta-hydroxyisovaleric acid
For Patients & Caregivers
Studies of HMB to prevent or reverse cancer-related muscle-wasting is limited and results are mixed.
HMB is a breakdown product of the amino acid leucine. Along with amino acids arginine and glutamine, these compounds are generally known to prevent or slow damage to muscle cells that occurs with intense exercise or in advanced cancers and AIDS. However, many of the findings stem from laboratory and animal studies, in healthy volunteers, or in athletes. Although more studies in elderly and ill patients have recently been conducted, only a few were in cancer patients, and those results are mixed.
- To prevent or reverse cancer- or HIV-related weight loss and weakness
There is limited research in these populations with conflicting results. Although two small studies in cancer patients showed some benefit, a larger study did not. Future trials should evaluate long-term safety and effects.
- To increase muscle mass
There is limited research in clinical populations and results are mixed. Small studies found that HMB may decrease muscle breakdown in bedridden elderly, but not hemodialysis patients. Another found that a formula containing HMB improved muscle strength in elderly women and hip fracture patients. However, further study is needed to confirm these effects.
- To improve strength and endurance in athletes
Clinical trials show mixed results regarding this use.
For Healthcare Professionals
Beta-hydroxy-beta-methylbutyrate (HMB) is a metabolite of the amino acid leucine. It is often used as a body building supplement to help improve muscle strength by reducing protein breakdown. HMB is also added to some medical foods for patients with muscle wasting and cachexia.
Small studies were initially conducted in active and younger men with mixed results on body composition and physical performance (1) (2) (3) (4) (5) (6). A systematic review suggests that HMB may prevent exercise-related muscle damage in healthy trained and untrained individuals, as well as muscle loss during chronic disease (7).
However, research on HMB in clinical populations is limited. Studies in the eldery show that HMB benefits vascular endothelial function (8), reduces muscle breakdown (9), decreases abdominal fat mass (10), improves functional recovery after hip fracture (11), and reduces mortality (12). Other study results are mixed. HMB improved pulmonary function in COPD patients (13) and nitrogen balance in critically injured patients (14), but did not reduce co-morbidities in hemodialysis patients (15).
HMB is often used together with glutamine and arginine for muscle wasting and cachexia in patients with AIDS (16) and cancer (17). However, a large randomized trial in patients with cancer cachexia failed to demonstrate a significant effect (18). Additional research is needed (19). A small study showed that an HMB-containing supplement may help prevent radiation dermatitis in head and neck cancer patients (20).
HMB is metabolized from the branched chain amino acid L-leucine endogenously through alpha-ketoisocaproic acid. Since only a small amount is converted from food sources, supplementation is used to increase intake. As a dietary supplement, HMB usually comes in calcium salt or free acid forms, the latter which is thought to have higher bioavailability (21). In muscle cells, HMB stimulates cell growth and survival through MAPK/ERK pathways (22). HMB restored balance between intracellular protein synthesis and breakdown by activating PI3K/Akt-dependent mammalian target of rapamycin (mTOR) (23) (24). The stimulating effect of HMB on mTOR is eliminated with the introduction of rapamycin, an mTOR inhibitor (6) (25). However, it is unclear if HMB supplementation would also reduce the therapeutic effects of other mTOR inhibitors used in cancer treatment. HMB inhibits the ubiquitin-proteasome proteolytic pathway which governs the degradation of intracellular proteins (26) . In murine neuroblastoma cells, HMB exihibited neurotrophic effects (27).
In animal models, HMB reduced total subcutaneous fat content and LDL cholesterol (28), but did not affect circulating plasma levels of testosterone (4), cortisol, insulin-like growth factor-1 (IGF-1), or insulin (29).